Back
ACVC Premium Access

Dual antiplatelet therapy in acute coronary syndrome, how long should we maintain it?

Session: Poster Session 3 - Antithrombotic therapy
Topic: Antithrombotic agents
Speaker: Mrs M. Merchan Cuenda (Badajoz, ES)
Event: Acute Cardiovascular Care 2016

Congress Presentation

Add to my library

Like

About the speaker

Mrs Mercedes Merchan Cuenda

Hospital Universitario Infanta Cristina, Badajoz (Spain)
0 follower

10 more presentations in this session

Protocol-based management of warfarin pharmacotherapy by pharmacists in perioperative cardiac surgery patients

Speaker: Mr M. Suzuki (Kamogawa, JP)

Access
Abstract
Like
Thumbnail

High on-treatment after aspirin loading dose platelet reactivity as a modifiable risk factor to tailor antiplatelet therapy in acute coronary syndrome

Speaker: Professor L. Malinova (Saratov, RU)

Access
Abstract
Slides
Like
Thumbnail

Prognostic impact of single antiplatelet therapy as a primary prevention strategy in the acute coronary syndromes setting

Speaker: Doctor L. Almeida Morais (Lisbon, PT)

Access
Abstract
Like
Thumbnail

Acute coronary syndrome and atrial fibrillation: benefit versus risk of triple antithrombotic therapy

Speaker: Doctor S. Guerreiro (Lisbon, PT)

Access
Abstract
Like
Thumbnail

Safety and efficacy of new antiplatelet drugs in elderly patients with acute coronary syndrome (SCENARIO I study)

Speaker: Doctor L. Madrona Jimenez (Seville, ES)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 3 - Antithrombotic therapy

Speakers: Mrs M. Merchan Cuenda, Mr M. Suzuki, Professor L. Malinova, Doctor L. Almeida Morais, Doctor S. Guerreiro...
Access
Like
Thumbnail

About the event

Image

Acute Cardiovascular Care 2016

15 October - 17 October 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources